Boxer Capital as of March 31, 2024
Portfolio Holdings for Boxer Capital
Boxer Capital holds 59 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 8.3 | $168M | 3.4M | 49.22 | |
| Cytokinetics Com New (CYTK) | 7.3 | $147M | 2.1M | 70.11 | |
| Revolution Medicines (RVMD) | 6.8 | $138M | 4.3M | 32.23 | |
| Tyra Biosciences (TYRA) | 5.2 | $106M | 6.4M | 16.40 | |
| Apellis Pharmaceuticals (APLS) | 5.0 | $102M | 1.7M | 58.78 | |
| Ideaya Biosciences (IDYA) | 4.8 | $97M | 2.2M | 43.88 | |
| Merus N V (MRUS) | 4.2 | $86M | 1.9M | 45.03 | |
| Sarepta Therapeutics (SRPT) | 4.2 | $84M | 650k | 129.46 | |
| Nuvalent Inc-a (NUVL) | 4.2 | $84M | 1.1M | 75.09 | |
| BeiGene Sponsored Adr (BGNE) | 3.9 | $78M | 500k | 156.39 | |
| Tango Therapeutics (TNGX) | 3.2 | $65M | 8.2M | 7.94 | |
| Nkarta (NKTX) | 3.0 | $61M | 5.6M | 10.81 | |
| Fate Therapeutics (FATE) | 3.0 | $60M | 8.2M | 7.34 | |
| Avidity Biosciences Ord (RNA) | 2.2 | $44M | 1.7M | 25.52 | |
| Akero Therapeutics (AKRO) | 2.1 | $42M | 1.7M | 25.26 | |
| Rocket Pharmaceuticals (RCKT) | 2.0 | $40M | 1.5M | 26.94 | |
| Argenx SE Sponsored Adr (ARGX) | 1.9 | $39M | 100k | 393.72 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.7 | $34M | 600k | 56.09 | |
| Axsome Therapeutics (AXSM) | 1.6 | $32M | 400k | 79.80 | |
| Arcus Biosciences Incorporated (RCUS) | 1.5 | $30M | 1.6M | 18.88 | |
| Anaptysbio Inc Common (ANAB) | 1.4 | $29M | 1.3M | 22.52 | |
| Immunovant (IMVT) | 1.3 | $27M | 825k | 32.31 | |
| Xenon Pharmaceuticals (XENE) | 1.3 | $26M | 600k | 43.05 | |
| Arvinas Ord (ARVN) | 1.2 | $25M | 609k | 41.28 | |
| Iteos Therapeutics (ITOS) | 1.2 | $25M | 1.8M | 13.64 | |
| Viking Therapeutics (VKTX) | 1.2 | $25M | 300k | 82.00 | |
| Oric Pharmaceuticals (ORIC) | 1.2 | $24M | 1.7M | 13.75 | |
| Kura Oncology (KURA) | 1.1 | $21M | 1.0M | 21.33 | |
| Geron Corporation (GERN) | 1.0 | $20M | 6.0M | 3.30 | |
| Day One Biopharmaceuticals I (DAWN) | 1.0 | $20M | 1.2M | 16.52 | |
| Third Harmonic Bio (THRD) | 0.9 | $19M | 2.0M | 9.44 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $19M | 1.6M | 11.86 | |
| Allogene Therapeutics (ALLO) | 0.8 | $17M | 3.9M | 4.47 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $17M | 400k | 42.86 | |
| Prothena Corp SHS (PRTA) | 0.8 | $17M | 690k | 24.77 | |
| Sana Biotechnology (SANA) | 0.8 | $16M | 1.5M | 10.00 | |
| Relay Therapeutics (RLAY) | 0.7 | $15M | 1.8M | 8.30 | |
| Poseida Therapeutics I (PSTX) | 0.7 | $14M | 4.5M | 3.19 | |
| Engene Holdings (ENGN) | 0.6 | $12M | 728k | 16.95 | |
| Prelude Therapeutics (PRLD) | 0.6 | $12M | 2.6M | 4.74 | |
| Enliven Therapeutics (ELVN) | 0.6 | $12M | 671k | 17.59 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $11M | 750k | 14.82 | |
| Jasper Therapeutics Com New (JSPR) | 0.5 | $10M | 350k | 29.36 | |
| Boundless Bio (BOLD) | 0.5 | $10M | 711k | 14.25 | |
| Spyre Therapeutics Com New (SYRE) | 0.5 | $9.5M | 250k | 37.93 | |
| Century Therapeutics (IPSC) | 0.4 | $7.3M | 1.8M | 4.18 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.4 | $7.1M | 450k | 15.76 | |
| Amylyx Pharmaceuticals (AMLX) | 0.2 | $4.3M | 1.5M | 2.84 | |
| Absci Corp (ABSI) | 0.2 | $4.0M | 700k | 5.68 | |
| Atara Biotherapeutics | 0.1 | $2.9M | 4.2M | 0.69 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $2.6M | 506k | 5.07 | |
| Direxion SHS ETF TR Daily S&p Biotec (LABD) | 0.1 | $2.6M | 350k | 7.29 | |
| Bioatla (BCAB) | 0.1 | $2.4M | 686k | 3.44 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.3M | 238k | 5.27 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $839k | 209k | 4.01 | |
| Milestone Pharmaceuticals (MIST) | 0.0 | $553k | 309k | 1.79 | |
| DBV Technologies S A Sponsored Adr | 0.0 | $375k | 500k | 0.75 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $81k | 267k | 0.30 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.2k | 67k | 0.03 |
